Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-11-14-Speech-3-168"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20011114.7.3-168"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Mr Caudron’s report adopts a position on the frameworks within which we should conduct research in Europe, financed by Community funds through the Sixth Framework Programme, and on the priorities we should be adopting.
As a Christian Democrat, I believe that we need ethical frameworks in society. These ethical frameworks must also exist where research is concerned. The most fundamental of these aspects is respect for human dignity. However worthy the objective may be, it does not justify our using people as a means to an end.
Research using embryo stem cells is ethically very controversial and, moreover, prohibited in four of the Member States. That is not the case when it comes to the use of adult stem cells. It is therefore my view that priority ought to be given to research using adult stem cells, while embryo stem cell research, which is deeply controversial from an ethical point of view, must not be allocated funds from the framework programme. Within the framework of the subsidiarity principle, that does not mean that national governments cannot choose to support the research.
Funds from the framework programme are, despite everything, limited. We are forced to prioritise. Support ought not, therefore, to be given to research which is ethically so controversial and is, moreover, clearly contrary to the legislation of several Member States. I have therefore chosen to support Amendment 334, to which I myself subscribed, where it says, in paragraph 4, that research using embryo stem cells must not be financed by Community funds, because the Member States disagree on this issue."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples